These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22174759)

  • 21. Cloning and characterization of guinea pig CXCR1.
    Takahashi M; Jeevan A; Sawant K; McMurray DN; Yoshimura T
    Mol Immunol; 2007 Feb; 44(5):878-88. PubMed ID: 16712933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation.
    Richardson RM; Pridgen BC; Haribabu B; Ali H; Snyderman R
    J Biol Chem; 1998 Sep; 273(37):23830-6. PubMed ID: 9726994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
    de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
    Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.
    Ringe J; Strassburg S; Neumann K; Endres M; Notter M; Burmester GR; Kaps C; Sittinger M
    J Cell Biochem; 2007 May; 101(1):135-46. PubMed ID: 17295203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
    Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
    J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
    Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
    Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
    Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma.
    Zhu LM; Zeng D; Lei XC; Huang J; Deng YF; Ji YB; Liu J; Dai FF; Li YZ; Shi DD; Zhu YQ; Dai AG; Wang Z
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165920. PubMed ID: 32800946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4.
    Sabroe I; Jones EC; Whyte MK; Dower SK
    Immunology; 2005 May; 115(1):90-8. PubMed ID: 15819701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2.
    Rose JJ; Foley JF; Murphy PM; Venkatesan S
    J Biol Chem; 2004 Jun; 279(23):24372-86. PubMed ID: 15028716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
    Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
    Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils.
    Petering H; Götze O; Kimmig D; Smolarski R; Kapp A; Elsner J
    Blood; 1999 Jan; 93(2):694-702. PubMed ID: 9885232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-bound chemokine CXCL8 monomer and dimer are impaired for CXCR1 and CXCR2 activation: implications for gradients and neutrophil trafficking.
    Joseph PRB; Sawant KV; Rajarathnam K
    Open Biol; 2017 Nov; 7(11):. PubMed ID: 29118271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXC chemokine receptor 1 (CXCR1) is expressed mainly by neutrophils in inflamed gut and stomach tissues.
    Ohtani N; Ohtani H; Oki M; Naganuma H; Nagura H
    Tohoku J Exp Med; 2002 Mar; 196(3):179-84. PubMed ID: 12002274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unraveling the evolutionary origin of ELR motif using fish CXC chemokine CXCL8.
    Gangele K; Jamsandekar M; Mishra A; Poluri KM
    Fish Shellfish Immunol; 2019 Oct; 93():17-27. PubMed ID: 31310848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.
    Khandaker MH; Xu L; Rahimpour R; Mitchell G; DeVries ME; Pickering JG; Singhal SK; Feldman RD; Kelvin DJ
    J Immunol; 1998 Aug; 161(4):1930-8. PubMed ID: 9712063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.